메뉴 건너뛰기




Volumn 9, Issue , 2015, Pages 3217-3229

Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway

Author keywords

Cardiac hypertrophy; IL 6; Isoproterenol; JAK STAT pathway; Simvastatin

Indexed keywords

CREATINE KINASE MB; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; ISOPRENALINE; JANUS KINASE; LIPID; SIMVASTATIN; STAT PROTEIN; TROPONIN I; BIOLOGICAL MARKER; STAT3 PROTEIN; STAT3 PROTEIN, RAT;

EID: 84933055813     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S86431     Document Type: Article
Times cited : (61)

References (75)
  • 1
    • 0034713820 scopus 로고    scopus 로고
    • Left ventricular hypertrophy: Pathogenesis, detection, and prognosis
    • Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 2000;102:470-479.
    • (2000) Circulation , vol.102 , pp. 470-479
    • Lorell, B.H.1    Carabello, B.A.2
  • 2
    • 0346098139 scopus 로고    scopus 로고
    • Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: Altered expression of apoptotic and cytoskeletal genes
    • Yung CK, Halperin VL, Tomaselli GF, Winslow RL. Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics. 2004;83:281-297.
    • (2004) Genomics , vol.83 , pp. 281-297
    • Yung, C.K.1    Halperin, V.L.2    Tomaselli, G.F.3    Winslow, R.L.4
  • 3
    • 0027751949 scopus 로고
    • Assessing the burden of mortality from cardiovascular diseases
    • Lopez AD. Assessing the burden of mortality from cardiovascular diseases. World Health Stat Q. 1993;46(2):91-96.
    • (1993) World Health Stat Q , vol.46 , Issue.2 , pp. 91-96
    • Lopez, A.D.1
  • 4
    • 53249090182 scopus 로고    scopus 로고
    • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
    • Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29(19):2388-2442.
    • (2008) Eur Heart J , vol.29 , Issue.19 , pp. 2388-2442
    • Dickstein, K.1    Cohen-Solal, A.2    Filippatos, G.3
  • 5
    • 0025266820 scopus 로고
    • Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications
    • Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81(4):1161-1172.
    • (1990) Circulation , vol.81 , Issue.4 , pp. 1161-1172
    • Pfeffer, M.A.1    Braunwald, E.2
  • 6
    • 0031907281 scopus 로고    scopus 로고
    • Pathological versus physiological left ventricular hypertrophy: A review
    • Richey PA, Brown SP. Pathological versus physiological left ventricular hypertrophy: a review. J Sports Sci. 2001;16(2):129-141.
    • (2001) J Sports Sci , vol.16 , Issue.2 , pp. 129-141
    • Richey, P.A.1    Brown, S.P.2
  • 7
    • 33644878001 scopus 로고    scopus 로고
    • Risk factors associated with myocardial infarction in Africa: The INTERHEART Africa study
    • Steyn K, Sliwa K, Hawken S, et al; INTERHEART Investigators in Africa. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation. 2005;112(23):3554-3561.
    • (2005) Circulation , vol.112 , Issue.23 , pp. 3554-3561
    • Steyn, K.1    Sliwa, K.2    Hawken, S.3    INTERHEART Investigators in Africa4
  • 9
    • 33746214582 scopus 로고    scopus 로고
    • Global changes in gene expression during cardiac hypertrophy: A new direction of cardiac signaling research
    • Usui S, Yeh I, Tian B, Sadoshima J. Global changes in gene expression during cardiac hypertrophy: a new direction of cardiac signaling research. J Mol Cell Cardiol. 2006;41(2):219-222.
    • (2006) J Mol Cell Cardiol , vol.41 , Issue.2 , pp. 219-222
    • Usui, S.1    Yeh, I.2    Tian, B.3    Sadoshima, J.4
  • 10
    • 34547449687 scopus 로고    scopus 로고
    • Involvement of transient receptor potential proteins in cardiac hypertrophy
    • Guinamard R, Bois P. Involvement of transient receptor potential proteins in cardiac hypertrophy. Biochim Biophys Acta. 2007;1172(8):885-894.
    • (2007) Biochim Biophys Acta , vol.1172 , Issue.8 , pp. 885-894
    • Guinamard, R.1    Bois, P.2
  • 11
    • 34249904441 scopus 로고    scopus 로고
    • The acute phase protein alpha2-macroglobulin induces rat ventricular cardiomyocyte hypertrophy via ERK1,2 and PI3-kinase/Akt pathways
    • Padmasekar M, Nandiqama R, Wartenberq M, Schluter KD, Sauer H. The acute phase protein alpha2-macroglobulin induces rat ventricular cardiomyocyte hypertrophy via ERK1,2 and PI3-kinase/Akt pathways. Cardiovasc Res. 2007;75(1):118-128.
    • (2007) Cardiovasc Res , vol.75 , Issue.1 , pp. 118-128
    • Padmasekar, M.1    Nandiqama, R.2    Wartenberq, M.3    Schluter, K.D.4    Sauer, H.5
  • 12
    • 34548392339 scopus 로고    scopus 로고
    • Role of diacylglycerol kinase in cellular regulatory processes: A new regulator for cardiomyocyte hypertrophy
    • Takeishi Y, Goto K, Kubota I. Role of diacylglycerol kinase in cellular regulatory processes: a new regulator for cardiomyocyte hypertrophy. Pharmacol Ther. 2007;115(3):352-359.
    • (2007) Pharmacol Ther , vol.115 , Issue.3 , pp. 352-359
    • Takeishi, Y.1    Goto, K.2    Kubota, I.3
  • 13
    • 37849023059 scopus 로고    scopus 로고
    • Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice
    • Boengler K, Buechert A, Heinen Y, et al. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res. 2008;102:131-135.
    • (2008) Circ Res , vol.102 , pp. 131-135
    • Boengler, K.1    Buechert, A.2    Heinen, Y.3
  • 14
    • 3342889421 scopus 로고    scopus 로고
    • Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury
    • Hilfiker-Kleiner D, Hilfiker A, Fuchs M, et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res. 2004;95:187-195.
    • (2004) Circ Res , vol.95 , pp. 187-195
    • Hilfiker-Kleiner, D.1    Hilfiker, A.2    Fuchs, M.3
  • 16
    • 42949120754 scopus 로고    scopus 로고
    • Identification of novel direct Stat3 target genes for control of growth and differentiation
    • Snyder M, Huang XY, Zhang JJL. Identification of novel direct Stat3 target genes for control of growth and differentiation. J Biol Chem. 2008;283:3791-3798.
    • (2008) J Biol Chem , vol.283 , pp. 3791-3798
    • Snyder, M.1    Huang, X.Y.2    Zhang, J.J.L.3
  • 17
    • 34250315274 scopus 로고    scopus 로고
    • Survival pathways in hypertrophy and heart failure: The gp130-STAT3 axis
    • Fischer P, Hilfiker-Kleiner D. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis. Basic Res Cardiol. 2007;102:279-297.
    • (2007) Basic Res Cardiol , vol.102 , pp. 279-297
    • Fischer, P.1    Hilfiker-Kleiner, D.2
  • 18
    • 0036852779 scopus 로고    scopus 로고
    • Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: Role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure
    • Booz GW, Day JNE, Baker KM. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol. 2002;34:1443-1453.
    • (2002) J Mol Cell Cardiol , vol.34 , pp. 1443-1453
    • Booz, G.W.1    Day, J.N.E.2    Baker, K.M.3
  • 19
    • 33747338922 scopus 로고    scopus 로고
    • JAK/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart
    • Terrell AM, Crisostomo PR, Wairiuko GM, Wang M, Morrell ED, Meldrum DR. JAK/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart. Shock. 2006;26:226-234.
    • (2006) Shock , vol.26 , pp. 226-234
    • Terrell, A.M.1    Crisostomo, P.R.2    Wairiuko, G.M.3    Wang, M.4    Morrell, E.D.5    Meldrum, D.R.6
  • 20
    • 44049091020 scopus 로고    scopus 로고
    • Clinical efficacy and safety of statins in managing cardiovascular risk
    • Kapur NK, Musunuru K. Clinical efficacy and safety of statins in managing cardiovascular risk. Vasc Health Risk Manag. 2008;4:341-453.
    • (2008) Vasc Health Risk Manag , vol.4 , pp. 341-453
    • Kapur, N.K.1    Musunuru, K.2
  • 21
    • 83755220049 scopus 로고    scopus 로고
    • Interplay between statins and PPARs in improving cardiovascular outcomes: A double-edged sword?
    • Balakumar P, Mahadevan N. Interplay between statins and PPARs in improving cardiovascular outcomes: a double-edged sword? Br J Pharmacol. 2012;165:373-379.
    • (2012) Br J Pharmacol , vol.165 , pp. 373-379
    • Balakumar, P.1    Mahadevan, N.2
  • 22
    • 33645223846 scopus 로고    scopus 로고
    • Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction
    • Iwakura K, Ito H, Kawano S, et al. Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction. Eur Heart J. 2006;27(5):534-539.
    • (2006) Eur Heart J , vol.27 , Issue.5 , pp. 534-539
    • Iwakura, K.1    Ito, H.2    Kawano, S.3
  • 23
    • 33748995111 scopus 로고    scopus 로고
    • Pretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial K(ATP) channel
    • Zhao JL, Yang YJ, Cui CJ, You SJ, Gao RL. Pretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial K(ATP) channel. Br J Pharmacol. 2006;149(3):243-249.
    • (2006) Br J Pharmacol , vol.149 , Issue.3 , pp. 243-249
    • Zhao, J.L.1    Yang, Y.J.2    Cui, C.J.3    You, S.J.4    Gao, R.L.5
  • 24
    • 35348975175 scopus 로고    scopus 로고
    • The cardioprotective effect of a statin and cilostazol combination: Relationship to Akt and endothelial nitric oxide synthase activation
    • Manickavasagam S, Ye Y, Lin Y, et al. The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation. Cardiovasc Drugs Ther. 2007;21(5):321-330.
    • (2007) Cardiovasc Drugs Ther , vol.21 , Issue.5 , pp. 321-330
    • Manickavasagam, S.1    Ye, Y.2    Lin, Y.3
  • 25
    • 34548421559 scopus 로고    scopus 로고
    • The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation
    • Merla R, Ye Y, Lin Y, et al. The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation. Am J Physiol Heart Circ Physiol. 2007;293(3):H1918-H1928.
    • (2007) Am J Physiol Heart Circ Physiol , vol.293 , Issue.3 , pp. H1918-H1928
    • Merla, R.1    Ye, Y.2    Lin, Y.3
  • 26
    • 0035141474 scopus 로고    scopus 로고
    • Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes
    • Luo JD, Xie F, Zhang WW, Ma XD, Guan JX, Chen X. Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes. Br J Pharmacol. 2001;132(1):159-164.
    • (2001) Br J Pharmacol , vol.132 , Issue.1 , pp. 159-164
    • Luo, J.D.1    Xie, F.2    Zhang, W.W.3    Ma, X.D.4    Guan, J.X.5    Chen, X.6
  • 27
    • 33745894649 scopus 로고    scopus 로고
    • Simvastatin attenuates hypertrophic responses induced by cardiotrophin-1 via JAK-STAT pathway in cultured cardiomyocytes
    • Wu L, Zhao L, Zheng Q, et al. Simvastatin attenuates hypertrophic responses induced by cardiotrophin-1 via JAK-STAT pathway in cultured cardiomyocytes. Mol Cell Biochem. 2006;284(1-2):65-71.
    • (2006) Mol Cell Biochem , vol.284 , Issue.1-2 , pp. 65-71
    • Wu, L.1    Zhao, L.2    Zheng, Q.3
  • 28
    • 42649089174 scopus 로고    scopus 로고
    • Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway
    • Liu J, Shen Q, Wu Y. Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway. Life Sci. 2008;82:991-996.
    • (2008) Life Sci , vol.82 , pp. 991-996
    • Liu, J.1    Shen, Q.2    Wu, Y.3
  • 30
    • 0019949179 scopus 로고
    • Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide
    • Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28(1):2077-2080.
    • (1982) Clin Chem , vol.28 , Issue.1 , pp. 2077-2080
    • Fossati, P.1    Prencipe, L.2
  • 31
    • 0014876627 scopus 로고
    • Rapid method for isolation of lipoprotein from human serum with polyanions
    • Burnstein M, Selvenick HR, Morfin R. Rapid method for isolation of lipoprotein from human serum with polyanions. J Lipid Res. 1970;11:583-595.
    • (1970) J Lipid Res , vol.11 , pp. 583-595
    • Burnstein, M.1    Selvenick, H.R.2    Morfin, R.3
  • 33
    • 0015348189 scopus 로고
    • Estimation of concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge
    • Friedewald WT. Estimation of concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18(7):499-502.
    • (1972) Clin Chem , vol.18 , Issue.7 , pp. 499-502
    • Friedewald, W.T.1
  • 34
    • 0002397219 scopus 로고
    • The pathogenesis of atherosclerosis
    • Braunwald E, editor, 4th ed. Philadelphia, PA: W. B. Saunders Company
    • Ross R. The pathogenesis of atherosclerosis. In: Braunwald E, editor. Heart Disease. 4th ed. Philadelphia, PA: W. B. Saunders Company; 1992;1106-1124.
    • (1992) Heart Disease , pp. 1106-1124
    • Ross, R.1
  • 35
    • 33846857559 scopus 로고    scopus 로고
    • Heart disease and stroke statistics - 2007 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    • Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics - 2007 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69-e171.
    • (2007) Circulation , vol.115 , pp. e69-e171
    • Rosamond, W.1    Flegal, K.2    Friday, G.3
  • 36
    • 77951152823 scopus 로고    scopus 로고
    • Myoglobin-deficient mice activate a distinct cardiac gene expression program in response to isoproterenol-induced hypertrophy
    • Molojavyi A, Lindecke A, Raupach A, Moellendorf S, Köhrer K, Gödecke A. Myoglobin-deficient mice activate a distinct cardiac gene expression program in response to isoproterenol-induced hypertrophy. Physiol Genomics. 2010;41:137-145.
    • (2010) Physiol Genomics , vol.41 , pp. 137-145
    • Molojavyi, A.1    Lindecke, A.2    Raupach, A.3    Moellendorf, S.4    Köhrer, K.5    Gödecke, A.6
  • 37
    • 0038795603 scopus 로고    scopus 로고
    • Regression of isoproterenol-induced cardiac hypertrophy by Na+/H+ exchanger inhibition
    • Ennis IL, Escudero EM, Console GM, et al. Regression of isoproterenol-induced cardiac hypertrophy by Na+/H+ exchanger inhibition. Hypertension. 2003;41:1324-1329.
    • (2003) Hypertension , vol.41 , pp. 1324-1329
    • Ennis, I.L.1    Escudero, E.M.2    Console, G.M.3
  • 38
    • 0037281330 scopus 로고    scopus 로고
    • Synergistic effect of nicorandil and amlodipine on tissue defense system during experimental myocardial infarction in rats
    • Sathish V, Ebenezar KK, Devaki T. Synergistic effect of nicorandil and amlodipine on tissue defense system during experimental myocardial infarction in rats. Mol Cell Biochem. 2003;243:133-138.
    • (2003) Mol Cell Biochem , vol.243 , pp. 133-138
    • Sathish, V.1    Ebenezar, K.K.2    Devaki, T.3
  • 40
    • 0021261142 scopus 로고
    • Development of isoproterenol-induced cardiac hypertrophy
    • Taylor PB, Tang Q. Development of isoproterenol-induced cardiac hypertrophy. Can J Physiol Pharmacol. 1984;62:384-389.
    • (1984) Can J Physiol Pharmacol , vol.62 , pp. 384-389
    • Taylor, P.B.1    Tang, Q.2
  • 41
    • 77955476705 scopus 로고    scopus 로고
    • Protective effects of Lagenaria siceraria (Molina) fruit juice in isoproterenol induced myocardial infarction
    • Upaganlawar A, Balaraman R. Protective effects of Lagenaria siceraria (Molina) fruit juice in isoproterenol induced myocardial infarction. Int J Pharmacol. 2010;6(5):645-651.
    • (2010) Int J Pharmacol , vol.6 , Issue.5 , pp. 645-651
    • Upaganlawar, A.1    Balaraman, R.2
  • 42
    • 84876442003 scopus 로고    scopus 로고
    • Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats
    • Li H, Xie YH, Yang Q, et al. Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats. PLoS One. 2012;7(11):e48872.
    • (2012) PLoS One , vol.7 , Issue.11
    • Li, H.1    Xie, Y.H.2    Yang, Q.3
  • 43
    • 77955771674 scopus 로고    scopus 로고
    • Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: A biochemical, electrocardiographic and histoarchitectural evaluation
    • Patel V, Upaganlawar A, Zalawadia R, Balaraman R. Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation. Eur J Pharmacol. 2010;644:160-168.
    • (2010) Eur J Pharmacol , vol.644 , pp. 160-168
    • Patel, V.1    Upaganlawar, A.2    Zalawadia, R.3    Balaraman, R.4
  • 44
    • 0013647072 scopus 로고
    • Hemodynamics during the chronic stage of myocardial damage caused by isoproterenol
    • Beznak M, Hacker P. Hemodynamics during the chronic stage of myocardial damage caused by isoproterenol. Can J Cardiol. 1964;42:269-274.
    • (1964) Can J Cardiol , vol.42 , pp. 269-274
    • Beznak, M.1    Hacker, P.2
  • 45
    • 0015880529 scopus 로고
    • Hemodynamics in the rat with isoproterenol induced cardiac hypertrophy
    • Lin YC. Hemodynamics in the rat with isoproterenol induced cardiac hypertrophy. Res Commun Chem Pathol Pharmacol. 1973;6:213-220.
    • (1973) Res Commun Chem Pathol Pharmacol , vol.6 , pp. 213-220
    • Lin, Y.C.1
  • 46
  • 47
    • 0023920657 scopus 로고
    • Contractile performance of papillary muscles of renovascular hypertensive and isoproterenol pretreated rats
    • Vassalo DV, Vasquez EC, Cabral AM. Contractile performance of papillary muscles of renovascular hypertensive and isoproterenol pretreated rats. Pharmacol Res Commun. 1988;20:61-72.
    • (1988) Pharmacol Res Commun , vol.20 , pp. 61-72
    • Vassalo, D.V.1    Vasquez, E.C.2    Cabral, A.M.3
  • 48
    • 0025148815 scopus 로고
    • Cardiac inotropic responses to calcium and foskolin are not altered by prolonged isoproterenol infusion
    • Bowling N, Wyss VL, Gengo PJ, Utterback B, Kauffman RF, Hayes IN. Cardiac inotropic responses to calcium and foskolin are not altered by prolonged isoproterenol infusion. Eur J Pharmacol. 1990;187:155-164.
    • (1990) Eur J Pharmacol , vol.187 , pp. 155-164
    • Bowling, N.1    Wyss, V.L.2    Gengo, P.J.3    Utterback, B.4    Kauffman, R.F.5    Hayes, I.N.6
  • 49
    • 33750813323 scopus 로고    scopus 로고
    • Relation between contractile function and regulatory cardiac proteins in hypertrophied hearts
    • Stein B, Bartel S, Kirchhefer U, et al. Relation between contractile function and regulatory cardiac proteins in hypertrophied hearts. Am J Physiol. 1996;270:H2021-H2028.
    • (1996) Am J Physiol , vol.270 , pp. H2021-H2028
    • Stein, B.1    Bartel, S.2    Kirchhefer, U.3
  • 50
    • 0026709230 scopus 로고
    • Functional changes in the right and left ventricle during development of cardiac hypertrophy and after its regression
    • Cihák R, Kolar F, Pelouch V, Prochazka J, Ostadal B, Widimsky J. Functional changes in the right and left ventricle during development of cardiac hypertrophy and after its regression. Cardiovasc Res. 1992;26:845-850.
    • (1992) Cardiovasc Res , vol.26 , pp. 845-850
    • Cihák, R.1    Kolar, F.2    Pelouch, V.3    Prochazka, J.4    Ostadal, B.5    Widimsky, J.6
  • 51
    • 0030727083 scopus 로고    scopus 로고
    • A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy
    • Arthur GD, Belcastro AN. A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy. Mol Cell Biochem. 1997;176:241-248.
    • (1997) Mol Cell Biochem , vol.176 , pp. 241-248
    • Arthur, G.D.1    Belcastro, A.N.2
  • 52
    • 0029893429 scopus 로고    scopus 로고
    • Altered contractile function in isoproterenol-induced hypertrophied rat heart
    • Tang Q, Taylor PB. Altered contractile function in isoproterenol-induced hypertrophied rat heart. J Hypertens. 1996;14:751-757.
    • (1996) J Hypertens , vol.14 , pp. 751-757
    • Tang, Q.1    Taylor, P.B.2
  • 53
    • 51049115136 scopus 로고    scopus 로고
    • Green tea attenuates angiotensin II induced cardiac hypertrophy in rats by modulating reactive oxygen species production and the Src/epidermal growth factor receptor/Akt signaling pathway
    • Papparella I, Ceolotto G, Montemurro D, et al. Green tea attenuates angiotensin II induced cardiac hypertrophy in rats by modulating reactive oxygen species production and the Src/epidermal growth factor receptor/Akt signaling pathway. J Nutr. 2008;138(9):1596-1601.
    • (2008) J Nutr , vol.138 , Issue.9 , pp. 1596-1601
    • Papparella, I.1    Ceolotto, G.2    Montemurro, D.3
  • 54
    • 27544512189 scopus 로고    scopus 로고
    • Preventive effect of Aegle marmelos leaf extract on isoprenaline induced myocardial infarction in rats: Biochemical evidence
    • Prince PS, Rajadurai M. Preventive effect of Aegle marmelos leaf extract on isoprenaline induced myocardial infarction in rats: biochemical evidence. J Pharm Pharmacol. 2005;57:1353-1357.
    • (2005) J Pharm Pharmacol , vol.57 , pp. 1353-1357
    • Prince, P.S.1    Rajadurai, M.2
  • 55
    • 68649091453 scopus 로고    scopus 로고
    • Simvastatin alleviates myocardial contractile dysfunction and lethal ischemic injury in rat heart independent of cholesterol-lowering effects
    • Adameova A, Harcarova A, Matejikova J, et al. Simvastatin alleviates myocardial contractile dysfunction and lethal ischemic injury in rat heart independent of cholesterol-lowering effects. Physiol Res. 2009;58:449-454.
    • (2009) Physiol Res , vol.58 , pp. 449-454
    • Adameova, A.1    Harcarova, A.2    Matejikova, J.3
  • 56
    • 33747033675 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1
    • Morikawa-Futamatsu K, Adachi S, Maejima Y, et al. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1. Life Sci. 2006;79(14):1380-1390.
    • (2006) Life Sci , vol.79 , Issue.14 , pp. 1380-1390
    • Morikawa-Futamatsu, K.1    Adachi, S.2    Maejima, Y.3
  • 57
    • 0035979347 scopus 로고    scopus 로고
    • Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor
    • Dechend R, Fiebeler A, Park JK, et al. Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor. Circulation. 2001;104(5):576-581.
    • (2001) Circulation , vol.104 , Issue.5 , pp. 576-581
    • Dechend, R.1    Fiebeler, A.2    Park, J.K.3
  • 58
    • 0033037565 scopus 로고    scopus 로고
    • Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB
    • Apple FS. Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB. Clin Chim Acta. 1999;284:151-159.
    • (1999) Clin Chim Acta , vol.284 , pp. 151-159
    • Apple, F.S.1
  • 59
    • 0031977811 scopus 로고    scopus 로고
    • Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure
    • Tsutamoto T, Hisanaga T, Wada A, et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 1998;31:391-398.
    • (1998) J Am Coll Cardiol , vol.31 , pp. 391-398
    • Tsutamoto, T.1    Hisanaga, T.2    Wada, A.3
  • 60
    • 0342424731 scopus 로고    scopus 로고
    • Prognostic value of serum cytokines in patients with congestive heart failure
    • Orús J, Roig E, Perez-Villa F, et al. Prognostic value of serum cytokines in patients with congestive heart failure. J Heart Lung Transplant. 2000;19:419-425.
    • (2000) J Heart Lung Transplant , vol.19 , pp. 419-425
    • Orús, J.1    Roig, E.2    Perez-Villa, F.3
  • 61
    • 0142010515 scopus 로고    scopus 로고
    • C reactive protein and interleukin-6 in vascular disease: Culprits or passive bystanders?
    • Rattazzi M, Puato M, Faggin E, Bertipaglia B, Zambon A, Pauletto P. C reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? J Hypertens. 2003;21:1787-1803.
    • (2003) J Hypertens , vol.21 , pp. 1787-1803
    • Rattazzi, M.1    Puato, M.2    Faggin, E.3    Bertipaglia, B.4    Zambon, A.5    Pauletto, P.6
  • 62
    • 16344367552 scopus 로고    scopus 로고
    • Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: Correlations with serum troponin I
    • Manginas A, Bei E, Chaidaroglou A, et al. Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: correlations with serum troponin I. Clin Cardiol. 2005;28:182-186.
    • (2005) Clin Cardiol , vol.28 , pp. 182-186
    • Manginas, A.1    Bei, E.2    Chaidaroglou, A.3
  • 63
    • 34249040813 scopus 로고    scopus 로고
    • Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome
    • Shu J, Ren N, Du JB, Zhang M, Cong HL, Huang TG. Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome. Scand Cardiovasc J. 2007;41:149-154.
    • (2007) Scand Cardiovasc J , vol.41 , pp. 149-154
    • Shu, J.1    Ren, N.2    Du, J.B.3    Zhang, M.4    Cong, H.L.5    Huang, T.G.6
  • 65
    • 0028997843 scopus 로고
    • Continuous activation of Gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice
    • Hirota H, Yoshida K, Kishimoto T, Taga T. Continuous activation of Gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci U S A. 1995;92:4862-4866.
    • (1995) Proc Natl Acad Sci U S A , vol.92 , pp. 4862-4866
    • Hirota, H.1    Yoshida, K.2    Kishimoto, T.3    Taga, T.4
  • 66
    • 0033514260 scopus 로고    scopus 로고
    • Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions
    • Gwechenberger M, Mendoza LH, Youker KA, et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation. 1999;99:546-551.
    • (1999) Circulation , vol.99 , pp. 546-551
    • Gwechenberger, M.1    Mendoza, L.H.2    Youker, K.A.3
  • 68
    • 0038393312 scopus 로고    scopus 로고
    • Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF kappa B in human colorectal cancer
    • Maihçfner C, Charalambous MP, Bhambra U, Lightfoot T, Geisslinger G, Gooderham NJ. Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF kappa B in human colorectal cancer. Carcinogenesis. 2003;24:665-671.
    • (2003) Carcinogenesis , vol.24 , pp. 665-671
    • Maihçfner, C.1    Charalambous, M.P.2    Bhambra, U.3    Lightfoot, T.4    Geisslinger, G.5    Gooderham, N.J.6
  • 69
    • 4644324186 scopus 로고    scopus 로고
    • NF-kappaB functions as a tumour promoter in inflammation-associated cancer
    • Pikarsky E, Porat RM, Stein I, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004;431:461-466.
    • (2004) Nature , vol.431 , pp. 461-466
    • Pikarsky, E.1    Porat, R.M.2    Stein, I.3
  • 70
    • 36749001714 scopus 로고    scopus 로고
    • Chemopreventive effect of plant originated glycoprotein on colitis-mediated colorectal cancer in A⁄J mice
    • Lee SJ, Lim KT. Chemopreventive effect of plant originated glycoprotein on colitis-mediated colorectal cancer in A⁄J mice. J Biomed Sci. 2008;15:111-121.
    • (2008) J Biomed Sci , vol.15 , pp. 111-121
    • Lee, S.J.1    Lim, K.T.2
  • 71
    • 84904111086 scopus 로고    scopus 로고
    • Rapamycin attenuated cardiac hypertrophy induced by isoproterenol and maintained energy homeostasis via inhibiting NF-κB activation
    • Chen X, Zeng S, Zou J, et al. Rapamycin attenuated cardiac hypertrophy induced by isoproterenol and maintained energy homeostasis via inhibiting NF-κB activation. Mediators Inflamm. 2014;2014:868753.
    • (2014) Mediators Inflamm , vol.2014
    • Chen, X.1    Zeng, S.2    Zou, J.3
  • 72
    • 37449022587 scopus 로고    scopus 로고
    • Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy
    • Serrano AL, Baeza-Raja B, Perdiguero E, Jardi M, Munoz-Cinoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 2008;7:33-44.
    • (2008) Cell Metab , vol.7 , pp. 33-44
    • Serrano, A.L.1    Baeza-Raja, B.2    Perdiguero, E.3    Jardi, M.4    Munoz-Cinoves, P.5
  • 73
    • 33847766236 scopus 로고    scopus 로고
    • Eccentric cardiac hypertrophy was induced by long term intermittent hypoxia in rats
    • Chen LM, Kuo WW, Yang JJ, et al. Eccentric cardiac hypertrophy was induced by long term intermittent hypoxia in rats. Exp Physiol. 2007;92:409-416.
    • (2007) Exp Physiol , vol.92 , pp. 409-416
    • Chen, L.M.1    Kuo, W.W.2    Yang, J.J.3
  • 74
    • 19944427539 scopus 로고    scopus 로고
    • STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart
    • Oshima Y, Fujio Y, Nakanishi T, et al. STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart. Cardiovasc Res. 2005;65(2):428-435.
    • (2005) Cardiovasc Res , vol.65 , Issue.2 , pp. 428-435
    • Oshima, Y.1    Fujio, Y.2    Nakanishi, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.